Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virus

Development, qualification, and validation of the Filovirus Animal Nonclinical Group anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay for human serum samples

(2019) Thomas L. Rudge et al.   PLoS One

Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates

(2019) John J. Suschak et al.   Human Vaccines & Immunotherapeutics

The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses

(2018) Tracey Goldstein et al.   Nature Microbiology

Pre-clinical toxicology considerations for vaccine development

(2017) Nabil Al-Humadi   VACCINE

Ebola and Marburg virus vaccines

(2017) Pierce Reynolds et al.   VIRUS GENES

Development of a Lethal Intranasal Exposure Model of Ebola Virus in the Cynomolgus Macaque

(2017) Kendra Alfson et al.   Viruses-Basel

Characterization of Sudan Ebolavirus infection in ferrets

(2017) Andrea Kroeker et al.   Oncotarget

Uganda grapples with new Marburg disease outbreak

(2017) Henry Wasswa   BMJ-British Medical Journal

Uganda grapples with new Marburg disease outbreak

(2017) Henry Wasswa   BMJ-British Medical Journal

The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species ofEbolavirus

(2016) Robert W. Cross et al.   JOURNAL OF INFECTIOUS DISEASES

Zika virus and microcephaly: why is this situation a PHEIC?

(2016) David L Heymann et al.   LANCET

Pandemic influenza - including a risk assessment of H5N1

(2016) J.K. TAUBENBERGER et al.   REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES

Experimental Respiratory Infection of Marmosets (Callithrix jacchus) With Ebola Virus Kikwit

(2015) Sophie J. Smither et al.   JOURNAL OF INFECTIOUS DISEASES

Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection: Table 1.

(2015) Thomas W. Geisbert et al.   JOURNAL OF INFECTIOUS DISEASES

Particle-to-PFU Ratio of Ebola Virus Influences Disease Course and Survival in Cynomolgus Macaques

(2015) Kendra J. Alfson et al.   JOURNAL OF VIROLOGY

Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial

(2015) Hannah Kibuuka et al.   LANCET

Ebola virus vaccines: an overview of current approaches

(2014) Andrea Marzi et al.   Expert Review of Vaccines

Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

(2014) Daphne A Stanley et al.   NATURE MEDICINE

Challenges, Progress, and Opportunities: Proceedings of the Filovirus Medical Countermeasures Workshop

(2014) Rona Hirschberg et al.   Viruses-Basel

Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Protects Nonhuman Primates from Intramuscular and Aerosol Challenge with Ebolavirus

(2013) A. S. Herbert et al.   JOURNAL OF VIROLOGY

Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates

(2012) Chad E. Mire et al.   PLoS Neglected Tropical Diseases

Recombinant Vesicular Stomatitis Virus–Based Vaccines Against Ebola and Marburg Virus Infections

(2011) Thomas W. Geisbert et al.   JOURNAL OF INFECTIOUS DISEASES

Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge

(2011) T. W. Geisbert et al.   JOURNAL OF VIROLOGY

A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults

(2010) J.E. Ledgerwood et al.   VACCINE

Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule

(2009) Nancy J. Sullivan et al.   NATURE REVIEWS MICROBIOLOGY